Characterization of immunoreactivity with whole-slide imaging and digital analysis in high-grade serous ovarian cancer
Ovarian cancer is the most lethal of gynecological cancers with 5-year survival rate of ca. 45%. The most common histologic subtype is high-grade serous carcinoma, which typically is presented with advanced stage and development of chemoresistance. Therefore, new treatment options, including immunot...
Saved in:
| Main Authors: | Tiina Jäntti, Satu Luhtala, Johanna Mäenpää, Synnöve Staff |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2020-11-01
|
| Series: | Tumor Biology |
| Online Access: | https://doi.org/10.1177/1010428320971404 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Risk Factors for Recurrence in Serous Borderline Ovarian Tumors and Early-Stage Low-Grade Serous Ovarian Carcinoma
by: Jingjing Zhang, et al.
Published: (2025-04-01) -
Immunotherapy that improves response to chemotherapy in high-grade serous ovarian cancer
by: Samar Elorbany, et al.
Published: (2024-11-01) -
Extracellular vesicles display distinct glycosignatures in high-grade serous ovarian carcinoma
by: Kristina Mae Bienes, et al.
Published: (2025-01-01) -
GATA3 and Aging Raise the Susceptibility of Metastasis to High-Grade Serous Ovarian Carcinoma
by: Mohnad Abdalla, et al.
Published: (2025-04-01) -
Functional study of laminin subunit α5 in high-grade serous ovarian cancer
by: Wang Tianli, et al.
Published: (2025-07-01)